Pricing Log in Create free account

Canton Strategic Holdings, Inc. (CNTN) vs MediWound Ltd. (MDWD)

Canton Strategic Holdings, Inc. and MediWound Ltd. are both Biotechnology companies. Canton Strategic Holdings, Inc. and MediWound Ltd. are of similar size ($157.6M and $149.0M). MediWound Ltd. has negative trailing earnings, so its P/E is not meaningful; Canton Strategic Holdings, Inc. trades at 9.0×. Canton Strategic Holdings, Inc. has the higher net margin (0.00% vs −170.1%) and the higher return on invested capital (−8.11% vs −6,551.8%). Across the 12 metrics below, Canton Strategic Holdings, Inc. leads on 11 and MediWound Ltd. on 1.

Valuation

Metric CNTN MDWD Biotechnology median
P/E 9.01 n/m 8.50
P/S n/m 12.87 9.71
P/B 0.81 4.28 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 9.97 9.21
Earnings yield 11.10% (13.50%) (33.15%)
Free cash flow yield (6.01%) (18.71%) (25.50%)

Profitability

Metric CNTN MDWD Biotechnology median
Gross margin — 15.46% 65.16%
Operating margin 0.00% (267.75%) 0.00%
Net margin 0.00% (170.10%) 0.00%
Free cash flow margin 0.00% (240.47%) 0.00%
Return on equity (43.10%) (75.42%) (56.36%)
Return on assets (34.60%) (29.06%) (48.04%)
Return on invested capital (8.11%) (6,551.77%) 0.00%

Growth

Metric CNTN MDWD Biotechnology median
Revenue growth (TTM) — (40.26%) 6.02%
EPS growth (last fiscal year) 88.10% 30.69% 30.26%
Revenue growth, 5-year CAGR — (4.87%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTN MDWD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.70 2.32 4.72
Net debt to EBITDA 0.85 2.27 0.96

Dividend

Metric CNTN MDWD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTN MDWD Biotechnology median
Market cap 149.01m 157.63m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack